Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.081 | 0.7 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |